Laura Brege - Net Worth and Insider Trading
Laura Brege Net Worth
The estimated net worth of Laura Brege is at least $960,075 dollars as of 2024-11-13. Laura Brege is the Director of Mirum Pharmaceuticals Inc and owns about 10,000 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $422,800. Laura Brege is the Director of Pacira BioSciences Inc and owns about 17,552 shares of Pacira BioSciences Inc (PCRX) stock worth over $295,049. Laura Brege is also the Director of ACADIA Pharmaceuticals Inc and owns about 13,502 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $242,226. Details can be seen in Laura Brege's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Brege has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laura Brege
Laura Brege Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura Brege owns 9 companies in total, including Portola Pharmaceuticals Inc (PTLA) , ACADIA Pharmaceuticals Inc (ACAD) , and Mirum Pharmaceuticals Inc (MIRM) among others .
Click here to see the complete history of Laura Brege’s form 4 insider trades.
Insider Ownership Summary of Laura Brege
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PTLA | Portola Pharmaceuticals Inc | 2020-07-02 | director |
ACAD | ACADIA Pharmaceuticals Inc | 2023-06-12 | director |
MIRM | Mirum Pharmaceuticals Inc | 2019-09-10 | director |
2024-08-16 | director | ||
2015-02-05 | director | ||
2018-07-27 | director | ||
2012-07-05 | director | ||
2009-12-10 | director | ||
2021-03-25 | director |
Laura Brege Latest Holdings Summary
Laura Brege currently owns a total of 3 stocks. Among these stocks, Laura Brege owns 10,000 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 10, 2019, with a value of $422,800 and a weighting of 44.04%. Laura Brege owns 17,552 shares of Pacira BioSciences Inc (PCRX) as of August 16, 2024, with a value of $295,049 and a weighting of 30.73%. Laura Brege also owns 13,502 shares of ACADIA Pharmaceuticals Inc (ACAD) as of June 12, 2023, with a value of $242,226 and a weighting of 25.23%.
Latest Holdings of Laura Brege
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MIRM | Mirum Pharmaceuticals Inc | 2019-09-10 | 10,000 | 42.28 | 422,800 |
PCRX | Pacira BioSciences Inc | 2024-08-16 | 17,552 | 16.81 | 295,049 |
ACAD | ACADIA Pharmaceuticals Inc | 2023-06-12 | 13,502 | 17.94 | 242,226 |
Holding Weightings of Laura Brege
Laura Brege Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura Brege has made a total of 0 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 10,000 shares on September 10, 2019, which cost Laura Brege around $112,200.
According to the SEC Form 4 filings, Laura Brege has made a total of 5 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Pacira BioSciences Inc is the acquisition of 1,000 shares on August 16, 2024, which cost Laura Brege around $12,810.
According to the SEC Form 4 filings, Laura Brege has made a total of 3 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 4,500 shares on June 12, 2023, which brought Laura Brege around $111,915.
Insider Trading History of Laura Brege
- 1
Laura Brege Trading Performance
GuruFocus tracks the stock performance after each of Laura Brege's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laura Brege is -5.99%. GuruFocus also compares Laura Brege's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laura Brege within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laura Brege's insider trading performs compared to the benchmark.
Performance of Laura Brege
Laura Brege Ownership Network
Ownership Network List of Laura Brege
Ownership Network Relation of Laura Brege
Laura Brege Owned Company Details
What does Portola Pharmaceuticals Inc do?
Who are the key executives at Portola Pharmaceuticals Inc?
Laura Brege is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .
Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Portola Pharmaceuticals Inc Insider Transactions
Laura Brege Mailing Address
Above is the net worth, insider trading, and ownership report for Laura Brege. You might contact Laura Brege via mailing address: C/o Onyx Pharmaceuticals, Inc., 2100 Powell Street, Emeryville Ca 94608.